Glenmark Pharmaceuticals Receives ANDA Approval for Clindamycin and Benzoyl Peroxide Gel, 1%|5%

/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin and Benzoyl Peroxide Gel, 1%|5%, a generic version of BenzaClin1 Gel, 1%|5%, of Valeant Bermuda.

(Logo: https://mma.prnewswire.com/media/451507/PRNE_Glenmark_Logo.jpg )
2Market includes brand and all available therapeutic equivalents
*IQVIATM National Sales Perspectives: Retail & Non-Retail, January 2019
About Glenmark Pharmaceuticals